about
New approaches for predicting T cell-mediated drug reactions: A role for inducible and potentially preventable autoimmunityTargeting the trimolecular complexType 1 diabetesMolecular Interactions Governing Autoantigen Presentation in Type 1 Diabetes2011 Update: antigen-specific therapy in type 1 diabetesImmunologic endocrine disorders.γδ T cells recognize the insulin B:9-23 peptide antigen when it is dimerized through thiol oxidation.Structure-based selection of small molecules to alter allele-specific MHC class II antigen presentationLessons from type 1 diabetes for understanding natural history and prevention of autoimmune disease.Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry.Autoimmune polyendocrine syndrome type 1 (APS-1) as a model for understanding autoimmune polyendocrine syndrome type 2 (APS-2).Immune intervention in type 1 diabetes.Anti-thymocyte globulin/G-CSF treatment preserves β cell function in patients with established type 1 diabetes.Specificity and detection of insulin-reactive CD4+ T cells in type 1 diabetes in the nonobese diabetic (NOD) mouse.Prediction and prevention of type 1 diabetes: update on success of prediction and struggles at preventionAlternate Ways to Quantify Antibodies.Exploring T cell reactivity to gliadin in young children with newly diagnosed celiac disease.Chromogranin A is a T cell antigen in human type 1 diabetes.The anti-insulin trimolecular complex in type 1 diabetes.Validation of a rapid type 1 diabetes autoantibody screening assay for community-based screening of organ donors to identify subjects at increased risk for the disease.Novel Management of Insulin Autoimmune Syndrome with Rituximab and Continuous Glucose Monitoring.Multiple Disease Associations in Autoimmune Polyglandular Syndrome Type II.Use of non-insulin therapies for type 1 diabetes.Transcription Factor 7-Like 2 () Gene Polymorphism and Progression From Single to Multiple Autoantibody Positivity in Individuals at Risk for Type 1 DiabetesImmunization with an insulin peptide-MHC complex to prevent type 1 diabetes of NOD miceAutoimmune polyglandular syndromesMalignant struma ovariiLearning From Past Failures of Oral Insulin TrialsAutoantibodies Directed Toward a Novel IA-2 Variant Protein Enhance Prediction of Type 1 DiabetesHybrid Insulin Peptides Are Autoantigens in Type 1 DiabetesImmune checkpoint inhibitor-induced Type 1 diabetes: a systematic review and meta-analysis
P50
Q26800973-4C23AF59-8491-4492-A075-39A566DEA94AQ26864985-D88CBB6C-D7A1-448D-A835-3B3703341ADEQ27000491-FE25F3A6-D3EF-4F49-8561-FF28660120F7Q28084487-EF83113C-AF78-4CB8-BE7D-82F60D6DD0A5Q33593629-D97AD998-E942-460A-8FF3-6CF94CDD3C03Q33714100-81828B48-FE99-4EE6-AF58-F61B479F07C4Q33880839-C19F3D40-7FAD-4595-9C75-C27ACBB6EFFDQ34063488-621F080A-BB44-4535-B0D9-3944C10843FBQ34604619-D1FF9BBA-5F45-418D-84D4-AB83654C1BCDQ34768952-0B98D5E8-5BB9-4DA9-9B9F-CB4CA40FDAE5Q34977007-00E494BB-7C34-4041-8EA6-A3FE87425CB2Q35226251-D286FD96-98C6-441F-B304-19D674D0A35BQ35242428-61ACC3CA-5746-4D64-9A3A-1AC904530B14Q35288506-591DA327-297B-40C1-B803-05F7FF83787FQ36117948-ECDB7536-A9CA-40B4-8959-6C6394BD3615Q36366700-4E89C021-2C13-4F45-805A-977DABC940C6Q37645021-15FA0B83-57FD-485F-ACE1-4B9454192E97Q37716863-D3ACA826-D066-4A70-8ED2-29A3D4EEB295Q37758077-5E5CA0E6-17E3-4A2E-9115-6C88860DF75CQ47626653-782F8624-19DA-400D-B515-2664F86E1CCFQ48060989-13FD3ED6-34E0-4706-9697-83EDE6983FAEQ50626294-38DA67B3-22E8-4189-8895-306BCE4F92FCQ54748056-77A6C47C-F872-4599-A610-28437907628AQ57054472-A0DB293A-EC9A-4417-B9E4-56086BF64EFAQ82436833-C0E2B2A2-40D7-417A-A34C-0CBC3823E6D7Q83823303-074A7052-BDC3-4705-8A7F-A3662C8B1FD2Q84019128-4474F6F4-172D-46A2-8506-DC615B21860FQ89206570-26F810AF-FBAF-42D7-9A6A-11933754AB58Q92547043-8BE378BF-DD7B-425A-97B0-B2C77C7F6AF9Q92594656-11516887-D24D-41FE-B013-21922C8D866EQ92744428-3F692F66-8B27-4A24-A89D-DEB57DF0BDCF
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Aaron W. Michels
@ast
Aaron W. Michels
@en
Aaron W. Michels
@es
Aaron W. Michels
@nl
Aaron W. Michels
@sl
type
label
Aaron W. Michels
@ast
Aaron W. Michels
@en
Aaron W. Michels
@es
Aaron W. Michels
@nl
Aaron W. Michels
@sl
prefLabel
Aaron W. Michels
@ast
Aaron W. Michels
@en
Aaron W. Michels
@es
Aaron W. Michels
@nl
Aaron W. Michels
@sl
P106
P1153
26432240400
P21
P31
P496
0000-0003-3766-5244